Barbara Deschler-Baier Selected Research

medullary Thyroid cancer

12/2023

Comparative Effectiveness of First-Line Selpercatinib versus Standard Therapies in Patients with RET-Activated Cancers: An Exploratory Interpatient Analysis of LIBRETTO-001.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Barbara Deschler-Baier Research Topics

Disease

7	Neoplasms (Cancer) 04/2024 - 01/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 12/2023
2	Thyroid Neoplasms (Thyroid Cancer) 12/2023 - 07/2022
1	Pheochromocytoma 04/2024
1	Melanoma (Melanoma, Malignant) 01/2024
1	Mesothelioma 01/2024
1	Triple Negative Breast Neoplasms 01/2024
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2024
1	medullary Thyroid cancer 12/2023
1	Lymphatic Metastasis 07/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Bites and Stings (Sting) 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Stomatitis 02/2016
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2016

Drug/Important Bio-Agent (IBA)

2	selpercatinibIBA 04/2024 - 12/2023
2	spartalizumabIBA 01/2024 - 01/2022
1	Phosphotransferases (Kinase)IBA 04/2024
1	DOTA(0)-Tyr(3)- 177Lu-octreotideIBA 07/2022
1	Radioisotopes (Radionuclides)IBA 07/2022
1	Peptide Receptors (Peptide Receptor)IBA 07/2022
1	PasotuxizumabIBA 01/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019

Therapy/Procedure

7	Therapeutics 04/2024 - 01/2019
1	Precision Medicine 07/2022
1	Castration 01/2021
1	Self Care (Care, Self) 02/2016
1	Hematopoietic Stem Cell Transplantation 02/2016
1	Chemoradiotherapy 02/2016